HM Payson & Co
- SEC CIK
- 0000928052
- Latest filing
- Jul 17, 2026
NVAX holding history
Novavax Inc in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVAX overviewAll 13F holders of NVAXFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −1,273−100.0% | Sold out | Holders |
| Q3 2023 | 1,273 | $9.22K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 1,273 | $9.46K | <0.1% | +65+5.4% | Added | Holders |
| Q1 2023 | 1,208 | $8.37K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 1,208 | $12.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 1,208 | $22.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 1,208 | $62.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 1,208 | $89.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 1,208 | $173.0K | <0.1% | +9+0.8% | Added | Holders |
| Q3 2021 | 1,199 | $249.0K | <0.1% | −200−14.3% | Reduced | Holders |
| Q2 2021 | 1,399 | $297.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 1,399 | $254.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.